Uterine tumors resembling ovarian sexcord tumors (UTROSCT) are very rare tumors that occur mainly in the uterine fundus of women in reproductive age. These tumors can be classified into group 1 and group 2 by histological results. In group 1, epithelial like differentiation is partially observed in the tumors. In group 2, sexcord elements are predominant in uterine mural mass. We experienced UTROSCT group 1 in a 29year old woman who complained of severe abdominal pain that started one week after delivery and UTROSCT group 2 case in a 49yearold woman who complained of dys functional uterine bleeding. We report two different types of UTROSCT cases that we experienced. (Ewha Med J 2020;43(1):19-23) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Introduction
Uterine tumors resembling ovarian sex-cord tumors (UTROSCT) are very rare tumors originating from the uterine body first named by Clement and Scully in 1976 [1] . They described 14 cases of UTROSCT and classified them into two groups according to clinical and histologic features. Each group is classified based on the amount of sex-cord like elements present. Group 1 tumors are endometrial stromal tumors with sex-cord-like element with more frequent metastasis and relapse rates, whereas group 2 tumors are predominantly consisted of sex-cord elements and has lower rates of metastasis and recurrence [2, 3] .
Clinically, these tumors occasionally secrete hormones that cause symptoms of abnormal vaginal bleeding. The UTROSCT are usually diagnosed clinically as endometrial polyps or leiomyomas, and are often confirmed through immunohistochemical or ultrastructural studies after surgery [4, 5] .
Both UTROSCT and endometrial stromal tumors with sexcord-like elementare masses that occur well in the uterine fundus, and macroscopic pathology findings show that polypoid masses are commonly projected into the uterine cavity.
The mean uterine weight and size are 485 g and 6.2 cm [3, 6] .
Microscopic findings show various architectural patterns such
as an anastomosing cord 1 to 2 cells wide, broad trabeculae, small nests, and sertoliform or retiform tubular structures, Call- [6, 7] . This tumor shows a variety of immunochemical profiles of sex cord (calretinin, inhibin, and CD99), epithelial (keratin and epithelial membrane antigen [EMA]), smooth muscle lineages (actin and desmin), and miscellaneous marker (CD10, estrogen receptor, and progesterone receptor) expression. CD99 (92.9%), calretinin (90.5%), CD56 (90%), progesterone receptor (88.9%), vimentin (88%), keratin (84.2%) were expressed very high, whereas CD10 (31.8%), EMA (18.8%) was low (Table 1 ) [3, 6, 7] . Shah et al. [8] described that the immunohistostaining results for inhibin and calretinin are significant in the diagnosis of UTROSCT.
The gold standard of UTROSCT treatment is simple hysterectomy with or without bilateral salpingo-oophorectomy. Anastrozole (aromatase inhibitor) and megestrol acetate are used in patients with recurrent UTROSCT [9] .
Differences in surgical methods showed no significant difference in disease-free survival (DFS). However pelvic pain, histologic subcategory, tumor size, disease spread and lymphovascular space invasion significantly reduced DFS. Postoperative overall survival rates of UTROSCT were good at 1 year (97.0%), 2 years (97.0%), and 5 years (97.0%). DFS rates were 1 year (97.0%), 2 years (92.7%), and 5 years (69.7%) after surgery. DFS rates for type 1, type 2 and unclassified group differences were 2 years (23.8% vs. 100% vs. 100%) and 5 years (0% vs. 50% vs. 81.8%) [3] .
In this study, we experienced two types of UTROSCT found in patients with different symptoms. Unlike group 1 UTROSCT cases that were previously reported, we observed a subserosal type of ruptured necrotic mass with the presence of hemoperitoneum in a young female patient who experienced abdominal pain after the delivery.
Case
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Case 1
A 29-year-old Korean woman, gravida 1, para 1, was ad- On macroscopic examination, the mass was approximately 6.5×6.5×1.5 cm and consisted of a hard solid mass with a grayish white capsule. The cut surface was heterogenous with multiple scattered old hemorrhages and white solid areas.
On microscopic examination, focal sex-cord-like differentiation was seen in the hemorrhagic background of proliferation of endometrioid stromal tumor cells (×100) (Fig. 1F ). Tumor cells are immunoreactive for CD10, used as a miscellaneous marker for UTROSCT (×200) (Fig. 1G) . Also the tumor cells immunostained positive with antibodies that recognize sexcord elements (calretinin) (×200) (Fig. 1H ). Thus the tumor was pathologically confirmed as group 1 UTROSCT. 
Uterine Tumors Resembling Ovarian Sex-cord Tumors
We performed a PET-CT scan in order to confirm the presence of metastasis to other organs in clinical correlation to results such as rupture of the mass and pathologic examination.
The PET-CT scan (Fig. 1I) showed an absence of other metastasis. The patient was recommended to have total abdominal hysterectomy and bilateral salpingo-oophorectomy surgery, but refused because she was considering additional pregnancy.
After meeting with the patient, an outpatient progress observation was taken. After 3 months, we re-performed a PET-CT scan ( Fig. 1J ) and confirmed no metastasis and recurrence. The patient no longer wanted future pregnancy, and thus, have total abdominal hysterectomy, bilateral salpingo-oophorectomy, omentectomy, and pelvic lymphadenectomy were performed at a different hospital. Post-surgery biopsy showed no metastasis and is currently on outpatient progress observation.
Case 2
A 49-year-old Korean woman, gravida 2, para 2, visited our hospital due to vaginal bleeding that began 3 weeks ago. A heterogeneously enhancing solid mass with a clear margin was observed in the uterus on MRI. On T2-weighted images, the non-enhancing portion of the tumor was seen as necrotic or cystic tissue ( Fig. 2A-C) . Hysterectomy and bilateral salpingooophorectomy were performed under the diagnosis of degenerated uterine myoma. Macroscopic examination showed the presence of a large yellow mass measured as 9.0×7.5 cm. The cut surface of the mass was soft, yellow, and homogeneous ( Fig. 2D, E) .
Upon microscopic examination, the microphotograph revealed cord-like, trabecular, and nested growth patterns of epithelioid cells. The tumor cells showed ovoid nuclei with irregular contours and occasional nuclear grooves, resembling granulosa cells of ovarian granulosa cell tumors (hematoxylin and eosin staining, ×200) (Fig. 2F) . The tumor cells stained positive with antibodies that recognize sex-cord elements (inhibin and CD99) ( Fig. 2G, H) and myoid differentiation (smooth muscle actin) ( Fig. 2I) , revealing positive expression. Thus the tumor was pathologically confirmed as group 2
UTROSCT.
There was no local recurrence or metastasis one year after discharge. In previous studies, 38 case reports were reviewed. UTROSCT were most commonly of the intramural type followed by the submucosal type, and the subserosal type was very rare [12] .
In this case, subserosal type UTROSCT with pain was misdi- Group 1 of UTROSCT have features similar to low grade endometrial stromal cancer and group 2 is known to show benign characteristics [2, 14] . Total abdominal hysterectomy and bilateral salpingo-oophorectomy are the main treatments for both groups, but uterine preservation surgery is performed in patients who want to preserve fertility [15] . In this case, only the tumors were removed under diagnosis of uterine leiomyoma in UTROSCT patients, but additional surgery was required post pathologic examination after the surgery. As a result, additional pathologic examination is necessary to distinguish other diseases such as UTROSCT after surgery in patients with suspected uterine leiomyoma with abdominal pain.
In conclusion, we performed tumor removal in a reproductive age woman diagnosed with group 1 UTROSCT, and then Furthermore, because of the rarity, preoperative radiologic and laboratory diagnostic tools for UTROSCT are yet to be established. Therefore, we conclude that further researches are needed to improve the rate of diagnosis.
